Oncology Fellows

September 2018

June 2018

March 2018

December 2017

September 2017

June 2017

March 2017

December 2016

September 2016
Volume: 8
Issue: 3

June 2016

March 2016
Volume: 8
Issue: 1

December 2015
Volume: 7
Issue: 4

September 2015
Volume: 7
Issue: 3

June 2015
Volume: 7
Issue: 2

March 2015
Volume: 7
Issue: 1

December 2014
Volume: 6
Issue: 4

September 2014
Volume: 6
Issue: 3

June 2014
Volume: 6
Issue: 2

March 2014
Volume: 6
Issue: 1

December 2013
Volume: 5
Issue: 4

October 2013
Volume: 5
Issue: 3

August 2013
Volume: 5
Issue: 2

May 2013
Volume: 5
Issue: 1

December 2012
Volume: 4
Issue: 4

September 2012
Volume: 4
Issue: 3

June 2012
Volume: 4
Issue: 2

April 2012
Volume: 4
Issue: 1

December 2011
Volume: 3
Issue: 4

October 2011
Volume: 3
Issue: 3

July 2011
Volume: 3
Issue: 2
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Daratumumab and Hyaluronidase Plus VRd for Newly Diagnosed Multiple Myeloma
2
PD-L1 Expression Is More Predictive of Response to Pembrolizumab on Metastatic Sites in High-Grade Serous Ovarian Cancer
3
Dr Braunstein on the FDA Approval of Subcutaneous Daratumumab With VRd For Newly Diagnosed Multiple Myeloma
4
Ixazomib-Containing Combinations Signal Potential for More PI-Based Regimens in R/R Multiple Myeloma
5

